The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls

Andreas Broocks, John T. Little, Alex Martin, Marcia D. Minichiello, Bellinda Dubbert, Carol Mack, Larry Tune, Dennis L. Murphy, Trey Sunderland

Research output: Contribution to journalArticle

Abstract

Background: There is evidence from animal and human experiments that leading and memory come under the separate influence of both cholinergic and serotonergic pathways. We were interested in learning whether serotonergic drugs could attenuate or exacerbate the memory-impairing effects of anticholinergic blockade in humans. Methods: The selective serotonin 5-HT3 receptor antagonist ondansetron (0.15 mg/kg IV) and the serotonergic agent m- chlorophenylpiperazine (m-CPP; 0.08 mg/kg IV) were administered in combination with the anticholinergic agent scopolamine (0.4 mg PO) and compared to scopolamine alone in 10 young, healthy volunteers. Testing occurred on three separate days. Results: As expected, IV administration of scopolamine induced significant impairments in episodic memory and processing speed; however, these scopolamine-induced cognitive deficits were not attenuated by pretreatment with IV ondansetron (0.15 mg/kg), nor were they exacerbated by administration of IV m-CPP (0.8 mg/kg) in addition to scopolamine; however, administration of IV m-CPP was followed by a significant increase of self-rated functional impairment, altered self- reality, and dysphoria ratings, and scopolamine's effect on pupil size was potentiated. Conclusions: Together, these results suggest that in young, healthy volunteers scopolamine-induced changes of cognitive performance are only minimally modulated by the serotonergic effects on ondansetron and m- CPP. Further studies with older controls are needed to test whether these findings may be influenced by age.

Original languageEnglish (US)
Pages (from-to)408-416
Number of pages9
JournalBiological Psychiatry
Volume43
Issue number6
DOIs
StatePublished - Mar 15 1998
Externally publishedYes

Fingerprint

Ondansetron
Scopolamine Hydrobromide
Serotonin Agents
Cholinergic Antagonists
Healthy Volunteers
Serotonin 5-HT3 Receptor Antagonists
Episodic Memory
Pupil
Cholinergic Agents
1-(3-chlorophenyl)piperazine
Learning

Keywords

  • Cognitive performance
  • m-chlorophenylpiperazine
  • Ondansetron
  • Scopolamine

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls. / Broocks, Andreas; Little, John T.; Martin, Alex; Minichiello, Marcia D.; Dubbert, Bellinda; Mack, Carol; Tune, Larry; Murphy, Dennis L.; Sunderland, Trey.

In: Biological Psychiatry, Vol. 43, No. 6, 15.03.1998, p. 408-416.

Research output: Contribution to journalArticle

Broocks, A, Little, JT, Martin, A, Minichiello, MD, Dubbert, B, Mack, C, Tune, L, Murphy, DL & Sunderland, T 1998, 'The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls', Biological Psychiatry, vol. 43, no. 6, pp. 408-416. https://doi.org/10.1016/S0006-3223(97)00388-0
Broocks, Andreas ; Little, John T. ; Martin, Alex ; Minichiello, Marcia D. ; Dubbert, Bellinda ; Mack, Carol ; Tune, Larry ; Murphy, Dennis L. ; Sunderland, Trey. / The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls. In: Biological Psychiatry. 1998 ; Vol. 43, No. 6. pp. 408-416.
@article{e692b533f7b34cd1948b9b9fefbc258c,
title = "The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls",
abstract = "Background: There is evidence from animal and human experiments that leading and memory come under the separate influence of both cholinergic and serotonergic pathways. We were interested in learning whether serotonergic drugs could attenuate or exacerbate the memory-impairing effects of anticholinergic blockade in humans. Methods: The selective serotonin 5-HT3 receptor antagonist ondansetron (0.15 mg/kg IV) and the serotonergic agent m- chlorophenylpiperazine (m-CPP; 0.08 mg/kg IV) were administered in combination with the anticholinergic agent scopolamine (0.4 mg PO) and compared to scopolamine alone in 10 young, healthy volunteers. Testing occurred on three separate days. Results: As expected, IV administration of scopolamine induced significant impairments in episodic memory and processing speed; however, these scopolamine-induced cognitive deficits were not attenuated by pretreatment with IV ondansetron (0.15 mg/kg), nor were they exacerbated by administration of IV m-CPP (0.8 mg/kg) in addition to scopolamine; however, administration of IV m-CPP was followed by a significant increase of self-rated functional impairment, altered self- reality, and dysphoria ratings, and scopolamine's effect on pupil size was potentiated. Conclusions: Together, these results suggest that in young, healthy volunteers scopolamine-induced changes of cognitive performance are only minimally modulated by the serotonergic effects on ondansetron and m- CPP. Further studies with older controls are needed to test whether these findings may be influenced by age.",
keywords = "Cognitive performance, m-chlorophenylpiperazine, Ondansetron, Scopolamine",
author = "Andreas Broocks and Little, {John T.} and Alex Martin and Minichiello, {Marcia D.} and Bellinda Dubbert and Carol Mack and Larry Tune and Murphy, {Dennis L.} and Trey Sunderland",
year = "1998",
month = "3",
day = "15",
doi = "10.1016/S0006-3223(97)00388-0",
language = "English (US)",
volume = "43",
pages = "408--416",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls

AU - Broocks, Andreas

AU - Little, John T.

AU - Martin, Alex

AU - Minichiello, Marcia D.

AU - Dubbert, Bellinda

AU - Mack, Carol

AU - Tune, Larry

AU - Murphy, Dennis L.

AU - Sunderland, Trey

PY - 1998/3/15

Y1 - 1998/3/15

N2 - Background: There is evidence from animal and human experiments that leading and memory come under the separate influence of both cholinergic and serotonergic pathways. We were interested in learning whether serotonergic drugs could attenuate or exacerbate the memory-impairing effects of anticholinergic blockade in humans. Methods: The selective serotonin 5-HT3 receptor antagonist ondansetron (0.15 mg/kg IV) and the serotonergic agent m- chlorophenylpiperazine (m-CPP; 0.08 mg/kg IV) were administered in combination with the anticholinergic agent scopolamine (0.4 mg PO) and compared to scopolamine alone in 10 young, healthy volunteers. Testing occurred on three separate days. Results: As expected, IV administration of scopolamine induced significant impairments in episodic memory and processing speed; however, these scopolamine-induced cognitive deficits were not attenuated by pretreatment with IV ondansetron (0.15 mg/kg), nor were they exacerbated by administration of IV m-CPP (0.8 mg/kg) in addition to scopolamine; however, administration of IV m-CPP was followed by a significant increase of self-rated functional impairment, altered self- reality, and dysphoria ratings, and scopolamine's effect on pupil size was potentiated. Conclusions: Together, these results suggest that in young, healthy volunteers scopolamine-induced changes of cognitive performance are only minimally modulated by the serotonergic effects on ondansetron and m- CPP. Further studies with older controls are needed to test whether these findings may be influenced by age.

AB - Background: There is evidence from animal and human experiments that leading and memory come under the separate influence of both cholinergic and serotonergic pathways. We were interested in learning whether serotonergic drugs could attenuate or exacerbate the memory-impairing effects of anticholinergic blockade in humans. Methods: The selective serotonin 5-HT3 receptor antagonist ondansetron (0.15 mg/kg IV) and the serotonergic agent m- chlorophenylpiperazine (m-CPP; 0.08 mg/kg IV) were administered in combination with the anticholinergic agent scopolamine (0.4 mg PO) and compared to scopolamine alone in 10 young, healthy volunteers. Testing occurred on three separate days. Results: As expected, IV administration of scopolamine induced significant impairments in episodic memory and processing speed; however, these scopolamine-induced cognitive deficits were not attenuated by pretreatment with IV ondansetron (0.15 mg/kg), nor were they exacerbated by administration of IV m-CPP (0.8 mg/kg) in addition to scopolamine; however, administration of IV m-CPP was followed by a significant increase of self-rated functional impairment, altered self- reality, and dysphoria ratings, and scopolamine's effect on pupil size was potentiated. Conclusions: Together, these results suggest that in young, healthy volunteers scopolamine-induced changes of cognitive performance are only minimally modulated by the serotonergic effects on ondansetron and m- CPP. Further studies with older controls are needed to test whether these findings may be influenced by age.

KW - Cognitive performance

KW - m-chlorophenylpiperazine

KW - Ondansetron

KW - Scopolamine

UR - http://www.scopus.com/inward/record.url?scp=0344476213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344476213&partnerID=8YFLogxK

U2 - 10.1016/S0006-3223(97)00388-0

DO - 10.1016/S0006-3223(97)00388-0

M3 - Article

C2 - 9532345

AN - SCOPUS:0344476213

VL - 43

SP - 408

EP - 416

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 6

ER -